291 related articles for article (PubMed ID: 33681652)
1. Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India.
Mehndiratta MM; Gulhane M; Jabeen SA; Patten A; Dash A; Malhotra M
Epilepsia Open; 2021 Mar; 6(1):90-101. PubMed ID: 33681652
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies.
Weiping L; Dong Z; Zhen H; Patten A; Dash A; Malhotra M
CNS Neurosci Ther; 2021 Mar; 27(3):330-340. PubMed ID: 33340263
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
[TBL] [Abstract][Full Text] [Related]
4. Sustained seizure freedom with adjunctive perampanel in patients with convulsive seizures: Post hoc analysis of open-label extension studies 307 and 332.
Resnick T; Patten A; Ngo LY; Malhotra M
Epilepsy Behav; 2022 Mar; 128():108528. PubMed ID: 35078116
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the long-term efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of open-label extension studies.
Piña-Garza JE; Villanueva V; Rosenfeld W; Yoshinaga H; Patten A; Malhotra M
Epilepsy Behav; 2022 Oct; 135():108901. PubMed ID: 36122531
[TBL] [Abstract][Full Text] [Related]
6. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.
Fogarasi A; Flamini R; Milh M; Phillips S; Yoshitomi S; Patten A; Takase T; Laurenza A; Ngo LY
Epilepsia; 2020 Jan; 61(1):125-137. PubMed ID: 31912493
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension.
Nishida T; Lee SK; Inoue Y; Saeki K; Ishikawa K; Malhotra M; Patten A; Kaneko S
Epilepsia Open; 2024 Apr; 9(2):501-512. PubMed ID: 37867420
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies.
Piña-Garza JE; Rosenfeld W; Saeki K; Villanueva V; Yoshinaga H; Patten A; Williams B; Malhotra M
Epilepsy Behav; 2020 Mar; 104(Pt A):106876. PubMed ID: 31954998
[TBL] [Abstract][Full Text] [Related]
9. Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307.
Krauss GL; Perucca E; Kwan P; Ben-Menachem E; Wang XF; Shih JJ; Patten A; Yang H; Williams B; Laurenza A
Epilepsia; 2018 Apr; 59(4):866-876. PubMed ID: 29574701
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
Steinhoff BJ; Patten A; Williams B; Malhotra M
Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy.
Brandt C; Wechsler RT; O'Brien TJ; Patten A; Malhotra M; Ngo LY; Steinhoff BJ
Seizure; 2020 Aug; 80():115-123. PubMed ID: 32563171
[TBL] [Abstract][Full Text] [Related]
12. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis.
Omatsu H; Watanabe T; Kira R; Ishiba K; Patten A; Takase T; Ngo LY
Seizure; 2023 Aug; 110():109-116. PubMed ID: 37336055
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations.
Nishida T; Lee SK; Wu T; Tiamkao S; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():47-59. PubMed ID: 30869168
[TBL] [Abstract][Full Text] [Related]
14. Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsy.
French JA; Wechsler RT; Trinka E; Brandt C; O'Brien TJ; Patten A; Salah A; Malhotra M
Epilepsia Open; 2022 Sep; 7(3):393-405. PubMed ID: 35445567
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and tolerability of perampanel in Asian and non-Asian patients with epilepsy.
Tsai JJ; Ikeda A; Hong SB; Likasitwattanakul S; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():37-46. PubMed ID: 30869165
[TBL] [Abstract][Full Text] [Related]
16. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
French JA; Krauss GL; Wechsler RT; Wang XF; DiVentura B; Brandt C; Trinka E; O'Brien TJ; Laurenza A; Patten A; Bibbiani F
Neurology; 2015 Sep; 85(11):950-7. PubMed ID: 26296511
[TBL] [Abstract][Full Text] [Related]
17. A post hoc analysis of the long-term safety and efficacy of perampanel in Asian patients with epilepsy.
Inoue Y; Kaneko S; Hsieh PF; Meshram C; Lee SA; Aziz ZA; Nabangchang C; Dash A
Epilepsia; 2019 Mar; 60 Suppl 1():60-67. PubMed ID: 30869167
[TBL] [Abstract][Full Text] [Related]
18. A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanel.
Krauss GL; Ben-Menachem E; Wechsler RT; Patten A; Williams B; Laurenza A; Malhotra M
Epilepsy Res; 2021 Aug; 174():106649. PubMed ID: 34022524
[TBL] [Abstract][Full Text] [Related]
19. Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures.
Tyrlikova I; Brazdil M; Rektor I; Tyrlik M
Expert Rev Neurother; 2019 Jan; 19(1):5-16. PubMed ID: 30560703
[No Abstract] [Full Text] [Related]
20. Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Study 508.
Ravat S; Rohatgi A; Kulkarni R; Jabeen SA; Patil B; Dash A; Malhotra M
Epilepsia Open; 2023 Dec; ():. PubMed ID: 38124551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
